ABBV
Income statement / Annual
Last year (2025), Abbvie Inc's total revenue was $61.16 B,
an increase of 8.57% from the previous year.
In 2025, Abbvie Inc's net income was $4.23 B.
See Abbvie Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$61.16 B |
$56.33 B |
$54.32 B |
$58.05 B |
$56.20 B |
$45.80 B |
$33.27 B |
$32.75 B |
$28.22 B |
$25.64 B |
| Cost of Revenue |
$9.97 B
|
$16.90 B
|
$20.42 B
|
$17.41 B
|
$17.45 B
|
$15.39 B
|
$7.44 B
|
$7.72 B
|
$7.04 B
|
$5.83 B
|
| Gross Profit |
$51.20 B
|
$39.43 B
|
$33.90 B
|
$40.64 B
|
$38.75 B
|
$30.42 B
|
$25.83 B
|
$25.04 B
|
$21.18 B
|
$19.81 B
|
| Gross Profit Ratio |
0.84
|
0.7
|
0.62
|
0.7
|
0.69
|
0.66
|
0.78
|
0.76
|
0.75
|
0.77
|
| Research and Development Expenses |
$9.10 B
|
$12.79 B
|
$7.68 B
|
$6.51 B
|
$8.05 B
|
$7.76 B
|
$6.79 B
|
$10.75 B
|
$5.33 B
|
$4.59 B
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$14.01 B
|
$14.75 B
|
$12.87 B
|
$15.26 B
|
$12.35 B
|
$11.30 B
|
$6.94 B
|
$7.40 B
|
$6.30 B
|
$5.88 B
|
| Other Expenses |
$6.88 B
|
$2.75 B
|
$599.00 M
|
$753.00 M
|
$432.00 M
|
$0.00
|
-$890.00 M
|
$500.00 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$29.98 B
|
$30.29 B
|
$21.15 B
|
$22.52 B
|
$20.83 B
|
$19.05 B
|
$12.84 B
|
$18.65 B
|
$11.63 B
|
$10.47 B
|
| Cost And Expenses |
$39.95 B
|
$47.20 B
|
$41.56 B
|
$39.94 B
|
$38.27 B
|
$34.44 B
|
$20.28 B
|
$26.37 B
|
$18.67 B
|
$16.30 B
|
| Interest Income |
$0.00
|
$648.00 M
|
$540.00 M
|
$186.00 M
|
$39.00 M
|
$174.00 M
|
$275.00 M
|
$204.00 M
|
$146.00 M
|
$82.00 M
|
| Interest Expense |
$2.63 B
|
$2.81 B
|
$2.22 B
|
$2.23 B
|
$2.42 B
|
$2.45 B
|
$1.78 B
|
$1.35 B
|
$1.15 B
|
$1.05 B
|
| Depreciation & Amortization |
$19.07 B
|
$8.39 B
|
$8.70 B
|
$8.47 B
|
$8.52 B
|
$6.47 B
|
$2.02 B
|
$1.77 B
|
$1.50 B
|
$1.19 B
|
| EBITDA |
$28.29 B |
$14.91 B |
$17.17 B |
$24.17 B |
$23.93 B |
$12.32 B |
$12.23 B |
$8.31 B |
$10.38 B |
$10.12 B |
| EBITDA Ratio |
0.46
|
0.26
|
0.32
|
0.42
|
0.43
|
0.27
|
0.37
|
0.25
|
0.37
|
0.39
|
| Operating Income Ratio |
0.35
|
0.16
|
0.23
|
0.31
|
0.32
|
0.25
|
0.39
|
0.19
|
0.34
|
0.36
|
| Total Other Income/Expenses Net |
-$14.62 B
|
-$5.42 B
|
-$6.51 B
|
-$4.64 B
|
-$4.94 B
|
-$7.97 B
|
-$4.56 B
|
-$1.19 B
|
-$1.82 B
|
-$1.46 B
|
| Income Before Tax |
$6.60 B
|
$3.72 B
|
$6.25 B
|
$13.48 B
|
$12.99 B
|
$3.40 B
|
$8.43 B
|
$5.20 B
|
$7.73 B
|
$7.88 B
|
| Income Before Tax Ratio |
0.11
|
0.07
|
0.12
|
0.23
|
0.23
|
0.07
|
0.25
|
0.16
|
0.27
|
0.31
|
| Income Tax Expense |
$2.36 B
|
-$570.00 M
|
$1.38 B
|
$1.63 B
|
$1.44 B
|
-$1.22 B
|
$544.00 M
|
-$490.00 M
|
$2.42 B
|
$1.93 B
|
| Net Income |
$4.23 B
|
$4.28 B
|
$4.86 B
|
$11.84 B
|
$11.54 B
|
$4.62 B
|
$7.88 B
|
$5.69 B
|
$5.31 B
|
$5.95 B
|
| Net Income Ratio |
0.07
|
0.08
|
0.09
|
0.2
|
0.21
|
0.1
|
0.24
|
0.17
|
0.19
|
0.23
|
| EPS |
2.38 |
2.4 |
2.73 |
6.65 |
6.48 |
2.73 |
5.3 |
3.69 |
3.31 |
3.65 |
| EPS Diluted |
2.36 |
2.39 |
2.72 |
6.63 |
6.45 |
2.72 |
5.28 |
3.68 |
3.3 |
3.63 |
| Weighted Average Shares Out |
$1.79 B
|
$1.77 B
|
$1.77 B
|
$1.77 B
|
$1.77 B
|
$1.67 B
|
$1.48 B
|
$1.54 B
|
$1.60 B
|
$1.62 B
|
| Weighted Average Shares Out Diluted |
$1.79 B
|
$1.77 B
|
$1.77 B
|
$1.78 B
|
$1.78 B
|
$1.67 B
|
$1.48 B
|
$1.55 B
|
$1.60 B
|
$1.63 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
